Alfred Health leads AI trial for epilepsy treatment
Source: Healthcare Asia
Australia’s Alfred Health is the lead site for PERSONAL, a clinical trial evaluating the use of AI in prescribing epilepsy medication.
Two groups are monitored for 12 months, with findings used to refine the AI model.
Australia’s Alfred Health is the lead site for PERSONAL, a clinical trial evaluating the use of artificial intelligence (AI) in prescribing epilepsy medication.
The tr… [315 chars]